StonvexLoading…
StonvexStonvexStonvexCore line items from MGNI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $713.95M | $668.17M | $619.71M | $577.07M |
Operating Income | $97.60M | $51.09M | $-155.01M | $-112.78M |
Net Income | $144.61M | $22.79M | $-159.18M | $-130.32M |
EPS (Diluted) | $0.95 | $0.16 | $-1.17 | $-0.98 |
Total Assets | $3.16B | $2.85B | $2.69B | $2.71B |
Total Liabilities | $2.24B | $2.09B | $1.99B | $1.92B |
Cash & Equivalents | $553.36M | $483.22M | $326.22M | $326.25M |
Free Cash Flow OCF − CapEx | $165.63M | $202.39M | $187.60M | $161.74M |
Shares Outstanding | 142.96M | 141.43M | 138.58M | 134.01M |